PubMed:8563133 / 239-443 JSONTXT

Annnotations TAB JSON ListView MergeView

    Glycosmos6-MAT

    {"project":"Glycosmos6-MAT","denotations":[{"id":"T3","span":{"begin":178,"end":187},"obj":"http://purl.obolibrary.org/obo/MAT_0000077"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":204},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":204},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":204},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T11","span":{"begin":57,"end":69},"obj":"FMAID:82737"},{"id":"_T12","span":{"begin":57,"end":69},"obj":"FMAID:197276"},{"id":"_T13","span":{"begin":178,"end":187},"obj":"FMAID:164956"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T3","span":{"begin":71,"end":74},"obj":"http://purl.obolibrary.org/obo/GO_0043848"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T4","span":{"begin":57,"end":69},"obj":"http://edamontology.org/topic_0152"},{"id":"T5","span":{"begin":131,"end":144},"obj":"http://edamontology.org/topic_3297"},{"id":"T6","span":{"begin":165,"end":170},"obj":"http://edamontology.org/topic_2815"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T2","span":{"begin":8,"end":14},"obj":"http://edamontology.org/data_2048"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    GlycoBiology-MAT

    {"project":"GlycoBiology-MAT","denotations":[{"id":"T3","span":{"begin":178,"end":187},"obj":"http://purl.obolibrary.org/obo/MAT_0000077"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    Anatomy-MAT

    {"project":"Anatomy-MAT","denotations":[{"id":"T3","span":{"begin":178,"end":187},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000077"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":178,"end":187},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0021156"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    NCBITAXON

    {"project":"NCBITAXON","denotations":[{"id":"T3","span":{"begin":165,"end":170},"obj":"OrganismTaxon"}],"attributes":[{"id":"A3","pred":"db_id","subj":"T3","obj":"9606"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}

    Anatomy-UBERON

    {"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":178,"end":187},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000007"}],"text":"In this report, we have compared the microheterogeneity, carbohydrate (CHO) content, mitogenic potency and immunoreactivity of the biotechnology product to those of human TSH of pituitary origin (pitTSH)."}